Company / Interest Expense
Xenetic Biosciences, Inc. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$249.9K
FY2025
5-year range
$100.5K / $355.8K
FY2021-FY2025
Trend
-29.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 10 years, ranging from -$1,818 in FY2018 to $729,572 in FY2017.
Based on SEC 10-K filings.
$249,861 in FY2025 with a 5-year CAGR of +18.2%.
Increased from $167,152 to $249,861 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +35.5%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +18.2%, indicating consistent growth.
- In FY2025, interest expense decreased 29.8% year-over-year.
- Peak interest expense was recorded in FY2017.
- Lowest interest expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $249.9K | -29.8% |
| FY2024 | $355.8K | +112.8% |
| FY2023 | $167.2K | +66.4% |
| FY2022 | $100.5K | -20.4% |
| FY2021 | $126.2K | +16.3% |
| FY2020 | $108.5K | +21214.1% |
| FY2019 | $509 | +128.0% |
| FY2018 | -$1.8K | -100.2% |
| FY2017 | $729.6K | +173.2% |
| FY2016 | $267.0K | +42146.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026